Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AEZS | F | AEterna Zentaris Inc. | -0.19 | |
AFMD | F | Affimed Therapeutics B.V. | 3.07 | |
AGRX | F | Agile Therapeutics, Inc. | 4.45 | |
ALNY | F | Alnylam Pharmaceuticals, Inc. | -0.28 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | -8.29 | |
APRE | D | Aprea Therapeutics, Inc. | -2.80 | |
ATRA | F | Atara Biotherapeutics, Inc. | -1.40 | |
AUPH | F | Aurinia Pharmaceuticals Inc | 0.82 | |
AXSM | D | Axsome Therapeutics, Inc. | 0.27 | |
BBIO | F | BridgeBio Pharma, Inc. | 2.26 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | D | ETFMG Treatments Testing and Advancements ETF | 6.36 | |
BBP | D | BioShares Biotechnology Products Fund | 6.2 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 5.24 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 4.85 | |
PILL | D | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 3.72 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles